(secondQuint)Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI.

 1.

 Evaluate the performance, safety and clinical benefit of MicroPort's aortic valve prosthesis and delivery system in intervention by peripheral artery.

 2.

 The study Continuous observe 12 months of safety and efficacy.

 Approximately 89 patients are recruited in the study with native aortic valve stenosis which are considered unsuitable for Surgical Valve Replacement.

.

 Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI@highlight

The objective of this study is to evaluate the safety and effectiveness of the MicroPort's Valve and delivery system for transcatheter aortic valve implantation (TAVI) in severe aortic stenosis who are considered unsuitable for Surgical Valve Replacement.

